studi
investig
valid
selfcollect
nose
throat
swab
influenza
confirm
commun
set
follow
outpati
confirm
influenza
sequenti
measur
viral
load
appli
loglinear
regress
model
viral
shed
pattern
among
outpati
confirm
influenza
detect
viru
quantit
viral
load
obtain
selfswab
consist
statist
predict
base
earlier
later
measur
suggest
selfcollect
nose
throat
swab
valid
altern
virolog
confirm
influenza
b
infect
commun
set
communitybas
studi
acut
respiratori
ill
clinic
specimen
upper
respiratori
tract
may
collect
patient
differ
stage
diseas
virolog
test
although
clinic
specimen
typic
collect
train
healthcar
profession
hcp
clinic
set
selfcollect
patient
home
may
accept
econom
logist
feasibl
altern
investig
whether
selfcollect
nose
throat
swab
ntss
patient
commun
set
could
provid
valid
altern
virolog
confirm
influenza
b
viru
infect
base
similarli
design
communitybas
studi
model
viral
shed
pattern
ill
onset
adjust
delay
clinic
symptom
onset
specimen
collect
compar
quantit
viral
load
measur
selfswab
modelbas
predict
method
conduct
separ
communitybas
studi
influenza
viru
infect
hong
kong
broadli
similar
protocol
recruit
followup
studi
outpati
recentonset
acut
respiratori
ill
present
within
hour
symptom
onset
recruit
individu
provid
inform
consent
posit
result
quickvu
influenza
rapid
diagnost
test
quidel
corp
invit
continu
followup
one
prospect
multicent
studi
influenza
resist
inform
studi
iri
patient
recruit
januari
novemb
follow
examin
natur
preval
andor
emerg
resist
antivir
among
circul
influenza
viru
strain
separ
household
transmiss
studi
ht
elig
patient
recruit
januari
septemb
follow
part
studi
investig
effect
nonpharmacolog
intervent
iri
ntss
collect
train
hcp
day
recruit
outpati
clinic
selfcollect
subject
home
day
receiv
detail
instruct
swab
techniqu
hcp
baselin
clinic
visit
nasal
swab
collect
insert
rotat
separ
flock
steril
swab
copan
nostril
posterior
nare
throat
swab
collect
swab
steril
flock
swab
tonsillar
fossa
posterior
pharynx
flock
end
nasal
swab
throat
swab
transfer
vial
contain
copan
univers
transport
medium
break
prescor
break
point
plastic
swab
shaft
specimen
collect
clinic
day
day
store
directli
clinic
refriger
collect
facetofac
instruct
perform
nasal
throat
swab
oneself
one
child
given
patient
parent
children
age
year
hcp
baselin
visit
day
patient
also
receiv
patient
instruct
leaflet
kit
contain
swab
individu
wrap
tongu
depressor
transport
medium
vial
sealabl
plastic
bag
patient
kept
day
swab
refriger
studi
investig
valid
selfcollect
nose
throat
swab
influenza
confirm
commun
set
follow
outpati
confirm
influenza
sequenti
measur
viral
load
appli
loglinear
regress
model
viral
shed
pattern
among
outpati
confirm
influenza
detect
viru
quantit
viral
load
obtain
selfswab
consist
statist
predict
base
earlier
later
measur
suggest
selfcollect
nose
throat
swab
valid
altern
virolog
confirm
influenza
b
infect
commun
set
communitybas
studi
acut
respiratori
ill
clinic
specimen
upper
respiratori
tract
may
collect
patient
differ
stage
diseas
virolog
test
although
clinic
specimen
typic
collect
train
healthcar
profession
hcp
clinic
set
selfcollect
patient
home
may
accept
econom
logist
feasibl
altern
investig
whether
selfcollect
nose
throat
swab
ntss
patient
commun
set
could
provid
valid
altern
virolog
confirm
influenza
b
viru
infect
base
similarli
design
communitybas
studi
model
viral
shed
pattern
ill
onset
adjust
delay
clinic
symptom
onset
specimen
collect
compar
quantit
viral
load
measur
selfswab
modelbas
predict
conduct
separ
communitybas
studi
influenza
viru
infect
hong
kong
broadli
similar
protocol
recruit
followup
studi
outpati
recentonset
acut
respiratori
ill
present
within
hour
symptom
onset
recruit
individu
provid
inform
consent
posit
result
quickvu
influenza
rapid
diagnost
test
quidel
corp
invit
continu
followup
one
prospect
multicent
studi
influenza
resist
inform
studi
iri
patient
recruit
januari
novemb
follow
examin
natur
preval
andor
emerg
resist
antivir
among
circul
influenza
viru
strain
separ
household
transmiss
studi
ht
elig
patient
recruit
januari
septemb
follow
part
studi
investig
effect
nonpharmacolog
intervent
iri
ntss
collect
train
hcp
day
recruit
outpati
clinic
selfcollect
subject
home
day
receiv
detail
instruct
swab
techniqu
hcp
baselin
clinic
visit
nasal
swab
collect
insert
rotat
separ
flock
steril
swab
copan
nostril
posterior
nare
throat
swab
collect
swab
steril
flock
swab
tonsillar
fossa
posterior
pharynx
flock
end
nasal
swab
throat
swab
transfer
vial
contain
copan
univers
transport
medium
break
prescor
break
point
plastic
swab
shaft
specimen
collect
clinic
day
day
store
directli
clinic
refriger
collect
facetofac
instruct
perform
nasal
throat
swab
oneself
one
child
given
patient
parent
children
age
year
hcp
baselin
visit
day
patient
also
receiv
patient
instruct
leaflet
kit
contain
swab
individu
wrap
tongu
depressor
transport
medium
vial
sealabl
plastic
bag
patient
kept
day
swab
refriger
home
collect
return
clinic
day
visit
specimen
sent
courier
insul
transport
contain
central
laboratori
erasmu
medic
centr
within
day
collect
ht
ntss
collect
train
hcp
home
visit
day
recruit
nasal
swab
collect
insert
rotat
steril
plain
swab
viscosetip
collect
swab
snappabl
plastic
stick
eurotubo
anterior
nare
throat
swab
collect
rub
second
steril
swab
tonsillar
fossa
swab
snap
tube
contain
viral
transport
medium
bovin
serum
albumin
earl
balanc
salt
solut
antibiot
specimen
store
insul
transport
contain
least
ice
pack
immedi
collect
specimen
either
deliv
directli
first
store
overnight
studi
outpati
clinic
refriger
deliv
next
day
central
test
laboratori
queen
mari
hospit
courier
ice
box
slightli
differ
laboratori
procedur
use
studi
iri
influenza
influenza
b
matrix
genespecif
reversetranscript
polymeras
chain
reaction
rtpcr
perform
describ
elsewher
dilut
electron
microscopiccount
influenza
viru
stock
advanc
bioscienc
advanc
biotechnolog
run
parallel
convers
rtpcr
threshold
cycl
ct
valu
quantit
measur
viral
particl
per
millilit
vpml
ht
sampl
elut
cryopreserv
immedi
receipt
laboratori
specimen
test
quantit
rtpcr
assay
detect
presenc
influenza
b
viru
determin
molecular
viral
load
rna
copi
per
millilit
copiesml
use
standard
method
describ
elsewher
previou
studi
suggest
follow
influenza
viru
infect
viral
load
rise
peak
around
time
ill
onset
influenza
declin
approxim
loglinearli
subsequ
day
undetect
level
influenza
b
plateau
gradual
declin
specifi
multivari
linear
regress
model
log
viral
load
first
third
measur
typic
day
respect
recruit
slope
separ
intercept
individu
allow
betweenperson
variabl
peak
viral
load
fit
separ
model
studi
influenza
b
adjust
age
oseltamivir
treatment
interact
term
time
includ
allow
slope
regress
line
vari
age
oseltamivir
treatment
viral
load
specimen
measur
load
lower
limit
quantif
lloq
imput
half
lloq
randomeffect
regress
model
construct
use
first
third
measur
use
predict
viral
load
expect
second
measur
typic
day
recruit
compar
observ
viral
load
second
swab
collect
patient
iri
hcp
ht
calcul
mean
differ
confid
interv
ci
base
distribut
one
hundr
thirtyeight
subject
confirm
influenza
confirm
influenza
b
recruit
iri
includ
age
year
rang
year
femal
prescrib
oseltamivir
treatment
one
hundr
eightyeight
subject
confirm
influenza
confirm
influenza
b
recruit
ht
age
year
rang
year
femal
prescrib
oseltamivir
treatment
demograph
characterist
subject
influenza
versu
b
similar
oseltamivir
treatment
common
period
peak
pandem
activ
data
shown
among
subject
posit
rtpcr
result
influenza
first
measur
selfswab
avail
subject
iri
detect
viru
selfcollect
swab
day
ill
onset
ht
hcpcollect
swab
subject
detect
viru
swab
day
ill
onset
influenza
b
correspond
statist
iri
day
onset
ht
day
onset
trend
influenza
viral
load
shown
figur
subject
iri
figur
subject
ht
iri
influenza
viral
load
determin
swab
taken
second
measur
slightli
lower
averag
expect
valu
base
randomeffect
regress
model
figur
mean
differ
observ
predict
viral
load
second
measur
ci
log
vpml
ht
viral
load
determin
swab
taken
second
measur
slightli
higher
averag
expect
valu
base
randomeffect
regress
model
figur
mean
differ
ci
log
copiesml
trend
influenza
b
viral
load
shown
figur
subject
iri
figur
subject
ht
studi
differ
observ
predict
viral
load
second
measur
small
statist
insignific
figur
iri
mean
differ
ci
log
vpml
ht
ci
log
copiesml
result
ht
swab
collect
train
hcp
show
viral
load
second
measur
could
accur
reliabl
predict
loglinear
model
base
first
third
measur
appli
approach
iri
data
found
viral
load
selfswab
second
measur
similar
viral
load
would
expect
second
swab
collect
train
hcp
result
therefor
support
feasibl
valid
use
selfswab
altern
approach
permit
laboratori
confirm
influenzaassoci
ill
commun
set
previou
studi
demonstr
feasibl
use
parentcollect
ntss
children
either
hospit
set
commun
set
laboratori
confirm
influenza
respiratori
viru
infect
without
signific
loss
sensit
result
extend
selfcollect
swab
patient
commun
set
qualit
diseas
confirm
quantit
viral
load
estim
iri
selfcollect
swab
contain
detect
influenza
viru
approxim
day
ill
onset
indic
substanti
loss
sensit
qualit
viru
detect
approach
ht
lower
proport
specimen
detect
viru
second
swab
attribut
slightli
longer
averag
delay
ill
onset
result
also
suggest
selfswab
work
gener
well
quantit
measur
viral
load
influenza
b
signific
differ
obtain
selfswab
valu
predict
swab
hcp
figur
influenza
overal
trend
viral
load
studi
also
appear
similar
figur
although
selfswab
iri
associ
lower
viral
load
predict
valu
figur
result
interpret
caution
differ
type
swab
transport
media
use
collect
site
techniqu
delay
collect
transport
laboratori
laboratori
procedur
studi
may
led
artifactu
differ
therefor
compar
predict
observ
viral
load
within
studi
result
studi
directli
compar
although
loglinear
model
fit
data
well
provid
reason
predict
viral
load
ht
figur
complex
model
might
better
repres
declin
viral
load
time
although
explicitli
model
shed
pattern
differ
influenza
subtyp
previous
identifi
substanti
differ
report
literatur
exist
valid
selfswab
longitudin
studi
influenza
viru
infect
ill
figur
ad
molecular
viral
load
first
third
measur
circl
second
measur
cross
influenza
influenza
resist
inform
studi
iri
household
transmiss
studi
ht
b
influenza
b
iri
c
ht
eh
differ
observ
expect
molecular
viral
load
vl
second
measur
histogram
summar
differ
influenza
iri
e
ht
f
influenza
b
iri
g
ht
h
second
measur
cross
collect
selfswab
iri
c
e
g
healthcar
profession
ht
b
f
h
iri
lower
limit
detect
llod
influenza
assay
viral
particl
per
millilit
vpml
lower
limit
quantif
lloq
vpml
llod
influenza
b
assay
vpml
lloq
vpml
ht
llod
influenza
b
assay
copiesml
lloq
copiesml
commun
set
need
multipl
sequenti
respiratori
specimen
cours
ill
studi
typic
requir
multipl
clinic
visit
patient
multipl
home
visit
hcp
thu
costli
complic
may
also
affect
studi
complianc
selfswab
would
thu
attract
altern
valid
approach
would
benefit
design
futur
communitybas
studi
studi
employ
collect
ntss
patient
hcp
parallel
random
fashion
could
help
enabl
finer
calibr
measur
obtain
selfswab
